BRIACELL THERAPEUTICS CORP. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
BRIACELL THERAPEUTICS CORP. (BCTX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $240.07 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2025-10-16
- BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $240.07K, a 85.85% decline from fiscal 2024.
- BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $1.70M, a 172.77% increase from fiscal 2023.
- BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $622.22K, a 24.94% decline from fiscal 2022.
- BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $828.93K, a 66.73% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-07-31 | $240.07K 10-K · filed 2025-10-16 |
| 2024-07-31 | $1.70M 10-K · filed 2025-10-16 |
| 2023-07-31 | $622.22K 10-K · filed 2024-10-29 |
| 2022-07-31 | $828.93K 10-K · filed 2023-10-25 |
| 2021-07-31 | $497.16K 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |